EP3450553
MRNA THERAPY FOR TREATMENT OF OCULAR DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.3.2015EP published:
25.12.2019EP application number:
18201321.9
EPO information:
European Patent Register
Max expiry date:
18.3.2035
Title:
MRNA THERAPY FOR TREATMENT OF OCULAR DISEASES
Timeline
Today
19.3.2015EP application
25.12.2019EP Publication
Owner
Name:
Translate Bio, Inc.Address:
29 Hartwell Avenue, Lexington, MA 02421, US
Inventor
Name:
CALIAS, PericlesAddress:
Lexington, MA 02421, US
Name:
DEROSA, FrankAddress:
Lexington, MA 02421, US
Name:
HEARTLEIN, MichaelAddress:
Lexington, MA 02421, US
Priority
Number:
201461969483 PDate:
24.3.2014Country:
US
Classification
Categories:
C12N 15/02, C12P 21/06, A61K 48/00